A Pharmacokinetic Study of Trabectedin in Patients With Advanced Malignancies and Hepatic Dysfunction

Update Il y a 4 ans
Reference: NCT01273493

Woman and Man

Extract

The purpose of this study is to characterize the pharmacokinetics (blood levels) of trabectedin after administration to patients with advanced malignancies and hepatic (liver) dysfunction.


Inclusion criteria

  • Neoplasm Metastases ,Hepatic Insufficiency


Links